BI Asset Management Fondsmaeglerselskab A S Purchases Shares of 32,877 Aflac Incorporated (NYSE:AFL)

BI Asset Management Fondsmaeglerselskab A S acquired a new position in Aflac Incorporated (NYSE:AFL - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 32,877 shares of the financial services provider's stock, valued at approximately $3,401,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Whipplewood Advisors LLC acquired a new stake in shares of Aflac in the 4th quarter valued at $26,000. BankPlus Trust Department acquired a new position in Aflac during the fourth quarter valued at approximately $34,000. Curio Wealth LLC acquired a new stake in shares of Aflac in the fourth quarter worth $36,000. OFI Invest Asset Management acquired a new position in Aflac in the 4th quarter valued at $38,000. Finally, Rialto Wealth Management LLC bought a new position in Aflac in the 4th quarter worth $41,000. Institutional investors own 67.44% of the company's stock.

Insider Buying and Selling at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the firm's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $107.63, for a total transaction of $107,630.00. Following the transaction, the director now owns 25,393 shares in the company, valued at approximately $2,733,048.59. This trade represents a 3.79 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Charles D. Lake II sold 29,802 shares of the company's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $107.29, for a total value of $3,197,456.58. Following the completion of the sale, the director now directly owns 49,962 shares of the company's stock, valued at approximately $5,360,422.98. This trade represents a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.90% of the company's stock.

Aflac Trading Down 1.1 %

AFL traded down $1.18 during mid-day trading on Friday, reaching $107.96. The stock had a trading volume of 1,829,733 shares, compared to its average volume of 2,001,196. The firm's fifty day simple moving average is $107.06 and its two-hundred day simple moving average is $107.16. The stock has a market capitalization of $58.93 billion, a P/E ratio of 11.25, a P/E/G ratio of 3.24 and a beta of 0.81. Aflac Incorporated has a 52 week low of $80.59 and a 52 week high of $115.50. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10.

Aflac (NYSE:AFL - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. On average, equities analysts predict that Aflac Incorporated will post 6.88 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. StockNews.com upgraded Aflac from a "sell" rating to a "hold" rating in a research note on Friday, February 14th. Wells Fargo & Company dropped their price objective on shares of Aflac from $104.00 to $102.00 and set an "equal weight" rating on the stock in a report on Wednesday, February 19th. Piper Sandler boosted their price target on Aflac from $118.00 to $124.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. Barclays lowered their price objective on Aflac from $98.00 to $95.00 and set an "underweight" rating on the stock in a research report on Friday, February 7th. Finally, Morgan Stanley cut their price target on shares of Aflac from $105.00 to $100.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $103.93.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.